1683 related articles for article (PubMed ID: 26048077)
21. Fast dimension reduction and integrative clustering of multi-omics data using low-rank approximation: application to cancer molecular classification.
Wu D; Wang D; Zhang MQ; Gu J
BMC Genomics; 2015 Dec; 16():1022. PubMed ID: 26626453
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping.
Sathyanarayanan A; Gupta R; Thompson EW; Nyholt DR; Bauer DC; Nagaraj SH
Brief Bioinform; 2020 Dec; 21(6):1920-1936. PubMed ID: 31774481
[TBL] [Abstract][Full Text] [Related]
23. Integration of pathway structure information into a reweighted partial Cox regression approach for survival analysis on high-dimensional gene expression data.
Liu W; Wang Q; Zhao J; Zhang C; Liu Y; Zhang J; Bai X; Li X; Feng H; Liao M; Wang W; Li C
Mol Biosyst; 2015 Jul; 11(7):1876-86. PubMed ID: 25891149
[TBL] [Abstract][Full Text] [Related]
24. Building trans-omics evidence: using imaging and 'omics' to characterize cancer profiles.
Srivastava A; Kulkarni C; Mallick P; Huang K; Machiraju R
Pac Symp Biocomput; 2018; 23():377-387. PubMed ID: 29218898
[TBL] [Abstract][Full Text] [Related]
25. A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification.
Chung RH; Kang CY
Gigascience; 2019 May; 8(5):. PubMed ID: 31029063
[TBL] [Abstract][Full Text] [Related]
26. Integrative pathway-based survival prediction utilizing the interaction between gene expression and DNA methylation in breast cancer.
Kim SY; Kim TR; Jeong HH; Sohn KA
BMC Med Genomics; 2018 Sep; 11(Suppl 3):68. PubMed ID: 30255812
[TBL] [Abstract][Full Text] [Related]
27. Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.
Lin Y; Zhang W; Cao H; Li G; Du W
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32759821
[TBL] [Abstract][Full Text] [Related]
28. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
29. Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer.
Malik V; Kalakoti Y; Sundar D
BMC Genomics; 2021 Mar; 22(1):214. PubMed ID: 33761889
[TBL] [Abstract][Full Text] [Related]
30. Robust pathway-based multi-omics data integration using directed random walks for survival prediction in multiple cancer studies.
Kim SY; Jeong HH; Kim J; Moon JH; Sohn KA
Biol Direct; 2019 Apr; 14(1):8. PubMed ID: 31036036
[TBL] [Abstract][Full Text] [Related]
31. Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.
Chaudhary K; Poirion OB; Lu L; Garmire LX
Clin Cancer Res; 2018 Mar; 24(6):1248-1259. PubMed ID: 28982688
[TBL] [Abstract][Full Text] [Related]
32. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
33. Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA.
Zhao Q; Shi X; Xie Y; Huang J; Shia B; Ma S
Brief Bioinform; 2015 Mar; 16(2):291-303. PubMed ID: 24632304
[TBL] [Abstract][Full Text] [Related]
34. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
[TBL] [Abstract][Full Text] [Related]
35. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
36. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ
BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048
[TBL] [Abstract][Full Text] [Related]
37. Group Lasso Regularized Deep Learning for Cancer Prognosis from Multi-Omics and Clinical Features.
Xie G; Dong C; Kong Y; Zhong JF; Li M; Wang K
Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30901858
[TBL] [Abstract][Full Text] [Related]
38. ATHENA: Identifying interactions between different levels of genomic data associated with cancer clinical outcomes using grammatical evolution neural network.
Kim D; Li R; Dudek SM; Ritchie MD
BioData Min; 2013 Dec; 6(1):23. PubMed ID: 24359638
[TBL] [Abstract][Full Text] [Related]
39. Integrative analysis of survival-associated gene sets in breast cancer.
Varn FS; Ung MH; Lou SK; Cheng C
BMC Med Genomics; 2015 Mar; 8():11. PubMed ID: 25881247
[TBL] [Abstract][Full Text] [Related]
40. Prediction of years of life after diagnosis of breast cancer using omics and omic-by-treatment interactions.
González-Reymúndez A; de Los Campos G; Gutiérrez L; Lunt SY; Vazquez AI
Eur J Hum Genet; 2017 May; 25(5):538-544. PubMed ID: 28272536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
